Use of Antibiotics during Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Hepatocellular Carcinoma

Use of Antibiotics during Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Hepatocellular Carcinoma

Background: Recent studies suggested that use of antibiotics may interfere with treatment responses to immune checkpoint inhibitors (ICIs). We determined whether concurrent use of antibiotics during ICI therapy was associated with adverse outcomes in patients with advanced hepatocellular carcinoma (...

Full description

Bibliographic Details
Main Authors: Ka Shing Cheung, Lok Ka Lam, Wai Kay Seto, Wai K. Leung
Format: Article
Language:English
Published: Karger Publishers 2021-08-01
Series:Liver Cancer
Subjects:
immunology
liver cancer
cirrhosis
hepatocellular carcinoma
Online Access:https://www.karger.com/Article/FullText/518090

Similar Items

Similar Items